Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 255

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

The Origin, Evolution, and Principles of Patient Navigation

Freeman, Harold P.·2012·Cancer Epidemiology, Biomarkers & Prevention

Abstract

This issue of CEBP focuses on patient navigation with specific emphasis on the findings of the National Cancer institute (NCI) Patient Navigation Research Program (PNRP). This research program was designed to develop interventions to reduce the time to diagnosis and treatment of cancer after identifying an abnormal finding from a cancer detection procedure. The basic goal of navigation is to facilitate timely access for all to quality standard care in a culturally sensitive manner. The concept for the NCI Patient Navigation Research Program was derived primarily from the original patient navigation concept and model, which was pioneered by Harold P. Freeman in Harlem, New York (1).The results of the NCI PNRP studies are well summarized by Byers in this issue of CEBP. The weight of evidence from the PNRP studies indicates that patient navigation can reduce the time from abnormal findings to diagnosis in breast, cervix, colorectal, and prostate cancer (2).Previous studies had already shown that patient navigation can increase participation in screening (3). Therefore, the sum of net benefits from patient navigation seems to be considerable. Current evidence suggests that patient navigation will be most beneficial to those at high risk for late diagnosis, such as the poor and uninsured. With respect to cost effectiveness, I agree with Byer's conclusion that it is likely that the modest cost of navigation will be easily offset by savings due to stage shifts that will result in the avoidance of the high costs of treating advanced cancer.The goal of this editorial is to place patient navigation in historical perspective, discuss the philosophy and principles of patient navigation, and show how this relatively new health care delivery support strategy has evolved since its inception in 1990.Patient navigation has evolved as a strategy to improve outcome in vulnerable populations by eliminating barriers to timely diagnosis and treatment of cancer and other chronic diseases. In 1989, the American Cancer Society held “National Hearings on Cancer in the Poor”. The hearings were led by the President of the Society and were conducted in seven American cities. The testimony was primarily by poor Americans of all racial and ethnic groups who had been diagnosed with cancer. On the basis of these hearings, the American Cancer Society issued its “Report to the Nation on Cancer in the Poor” (4).The report concluded that the most critical issues confronting poor people with cancer are as follows:These findings led to the concept of patient navigation. The nation's first patient navigation program was initiated by Freeman in 1990 at a public hospital in Harlem, New York. The original program focused on the critical window of opportunity to save lives from cancer by eliminating barriers to timely care between the point of suspicious finding and the resolution of the finding by diagnosis and treatment. The aim was to diminish the extremely high breast cancer death rate in a population of poor black women, half of whom had presented with late-stage breast cancer.Commonly experienced barriers to timely care in Harlem were:Subsequently, the scope of patient navigation was expanded to be applied across the entire health care continuum, including prevention, detection, diagnosis, treatment and survivorship to the end of life (Fig. 1). Retrospective studies of the Harlem hospital breast cancer experience showed that the combined interventions of patient navigation and free or low cost breast cancer screening resulted in an significantly increase in early-stage cancer diagnosis and treatment and marked increased 5-year survival (39%–70%) in a population of all poor and half uninsured black women (5, 6).Over the past decade, the federal government has provided significant funding for patient navigation research. Research has been supported by the National Cancer Institute the Center's for Medicare and Medicaid Services (CMS), the Center for Disease Control and the Health Resources and Services Administration (HRSA). In 2005, President George Bush signed the Patient Navigator and Chronic Disease Prevention Act. This leglistration provided funding to HRSA for patient navigation demonstration research. In 2012, the American College of Surgeons Commission on Cancer mandated that Patient Navigation is to be a standard of care to be met by cancer programs seeking approval beginning in the year 2015. The Affordable Care Act (ACA) includes references to patient navigation. The ACA requires that states establish exchanges to facilitate access to health insurance coverage for individuals. The ACA also requires that each state health insurance exchange establish a “navigator program” to help individuals make informed decisions about enrolling in health insurance through the exchange. The ACA extends the length of the Patient Navigator and Chronic Disease Prevention Act grant program to 2015. In 2012, the Patient Navigation Assistance Act is being i

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1055-9965.epi-12-0982

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 255

Metadata

Authors
Freeman, H. P.
Venue
Cancer Epidemiology, Biomarkers & Prevention
Published
2012-10-01
Volume
21
Issue
10
Pages
1614-1617
ISSN
  • 1055-9965 (ISSN-L)
  • 1538-7755
OpenAlex
W2133621586
Cited by
255
References
8
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Origin, Evolution, and Principles of Patient Navigation. https://app.cochat.ai/papers/10.1158/1055-9965.epi-12-0982
The paper
Freeman, H. P. (2012). The Origin, Evolution, and Principles of Patient Navigation. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-12-0982

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.